Woolsey v. Marion Laboratories, Inc.

934 F.2d 1452
CourtCourt of Appeals for the Tenth Circuit
DecidedJune 4, 1991
DocketNo. 90-6011
StatusPublished

This text of 934 F.2d 1452 (Woolsey v. Marion Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Woolsey v. Marion Laboratories, Inc., 934 F.2d 1452 (10th Cir. 1991).

Opinion

STEPHEN H. ANDERSON, Circuit Judge.

Jim L. Woolsey brought this action in district court against Marion Laboratories, Inc. (“Marion”) and the Marion Laboratories, Inc. Profit Sharing Plan (the “Plan”), (collectively referred to as “defendants”), claiming that the form in which the Plan distributed his vested benefits violated 29 U.S.C. §§ 1132 and 1140, part of the Employee Retirement Income Security Act (“ERISA”). On appeal, Woolsey, first, seeks reversal of the district court order granting summary judgment to the defendants and, second, claims that the district court erred in denying his motion to amend. We affirm.

BACKGROUND

Mr. Woolsey worked for Marion for over seventeen years until he resigned on November 11, 1985. Throughout Woolsey’s employ, Marion maintained the Plan, subject to the provisions of ERISA, to pay benefits to eligible employees upon retirement, death, disability, or other separation from service. The Plan is funded with annual contributions from Marion, with all such monies, once contributed, belonging irrevocably to the Plan. The Plan Administrators, appointed by the Marion Board of Directors, also serve as officers of Marion. When Woolsey resigned, he was 100% vested in the Plan and was entitled to $234,-631.82 in benefits.

[1453]*1453In a letter dated November 27, 1985, Marion asked Woolsey whether he preferred to receive the portion of his vested benefit allocated to the Marion Fund (a particular fund invested primarily in Marion stock) in cash, stock, a combination of the two or periodic cash installment payments. Woolsey requested 50% of his benefit to be paid in cash and the remaining 50% in Marion stock. After a claims review meeting on February 24, 1986, the Administrators exercised the discretion reserved to them under Section 7.1 of the Plan and denied Woolsey’s request. They then informed Woolsey of their decision and tendered checks to him for the full amount of his vested benefit. A short time later, a stock split occurred, significantly increasing the value of Marion stock.

Woolsey returned the checks to Marion and requested that Marion issue a check for half of the amount due from the Marion Fund ($109,856.65) and requested a review of the Administrators’ decision regarding the form of the other half of his benefit payment. Marion complied and issued the check, noting that Woolsey’s request had been denied because of the “special circumstances surrounding [his] termination.” R. Doc. 41, Exh. B-6. Subsequently Marion advised Woolsey that a hearing would be held on December 15, 1986.

At the December hearing, the Administrators heard from Charlie Dalton, counsel for Marion, and two employees of Marion— Norm Craig, a regional manager, and Steve Krohne, manager of personnel support services. They presented the following evidence: In July, Woolsey had been informed by Myrna West, his new district manager, that she did not care how he had sold pharmaceuticals in the past, but she wanted to run a “clean ship” from then on. Woolsey allegedly told her that she would not discover any unethical activities as she reviewed the books. In early September, West told Craig that she had discovered that Woolsey had been selling pharmaceuticals outside his designated area for some time. Craig and Krohne flew down to Oklahoma to talk with Woolsey and get more information about what may have happened. Craig stated that he did not intend to “nail” Woolsey and, indeed, had a great deal of respect for Woolsey who had become a member of the Marion “M Club,” “the most coveted [salesmanship] organization in th[e] company.” R. Doc. 41, Exh. G at 22. Woolsey allegedly admitted to Craig that, after he had spoken with West, he had breached Marion policy and procedure by working outside the boundaries of his territory, essentially stealing sales from his coworkers, and adding samples and stock pharmaceuticals to regular orders in order to “sweeten the pot” and encourage pharmacists to place larger orders. Woolsey also allegedly admitted that he had falsely reported lost pharmacy orders to obtain the replacement drugs and to give large amounts of credit to his customers. Craig and Krohne stayed in Oklahoma for three days, talking with West, Woolsey and several other employees. They then returned to Kansas and reported their findings to the senior management at Marion. The Marion officials requested Woolsey to come to Kansas, presumably for further investigation and discussion. Woolsey then resigned and refused to go to Kansas.

After presentation of this information, Woolsey and his attorney were allowed to enter the room and submit any information or arguments for reversal of the Administrators’ prior decision regarding the form of payments to Woolsey. Woolsey’s counsel argued that the acts taken by the Administrators were not in the best interests of the beneficiaries, that they had acted improperly because of an alleged conflict of interest and that any discipline for Wool-sey’s alleged misconduct should have been part of his termination proceedings, not part of his benefit payment proceedings. He also argued that Woolsey had been deprived of a property right in his vested benefits and that an employee’s conduct should serve as the basis for the Plan’s vesting requirements, not for determining the form of vested payments.

The Administrators subsequently informed Woolsey that they affirmed their prior decision that “special circumstances” existed justifying the denial of the stock distribution. Such circumstances included, [1454]*1454but were not limited to, a number of Wool-sey’s abuses of company policy: pursuing and obtaining orders for Marion products outside his assigned territory; supplying customers with sample and stock pharmaceuticals to persuade them to increase or place an order with himself; writing unauthorized credits to pharmacies for “lost” product; and, obtaining additional product to “buy orders” from customers. In addition, they noted that Woolsey had been advised that he must discontinue such practices by his superior and had not. They stated:

The Administrators believe that if they were to reward associates leaving under less than admirable conditions by granting them Marion stock, the stock price would likely decrease to the detriment of the remaining participants in the Plan, which would have not only an adverse monetary affect on the overall value of the Plan, but an adverse affect on associate morale as well.

R. Doc. 41, Exh. B-10 at 2.

The defendants admit that this is the first time that the Administrators have ever denied an otherwise eligible associate’s request for payment of half of his benefits in stock.

Woolsey filed his complaint on April 18, 1988 alleging that he had been denied his vested benefit rights in violation of 29 U.S.C. § 1132 and that the Plan had discriminated against him in violation of 29 U.S.C. § 1140. On March 31, 1989, the defendants filed a motion to dismiss, or in the alternative, for summary judgment. Both parties extensively briefed that motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nichols v. Eaton
91 U.S. 716 (Supreme Court, 1875)
Alessi v. Raybestos-Manhattan, Inc.
451 U.S. 504 (Supreme Court, 1981)
Firestone Tire & Rubber Co. v. Bruch
489 U.S. 101 (Supreme Court, 1989)
Guidry v. Sheet Metal Workers National Pension Fund
493 U.S. 365 (Supreme Court, 1990)
Jack D. Denton v. First National Bank of Waco, Texas
765 F.2d 1295 (First Circuit, 1985)
De Nobel v. Vitro Corp.
885 F.2d 1180 (Fourth Circuit, 1989)
Donovan v. Bierwirth
680 F.2d 263 (Second Circuit, 1982)
Fine v. Semet
699 F.2d 1091 (Eleventh Circuit, 1983)
Morse v. Stanley
732 F.2d 1139 (Second Circuit, 1984)
Weir v. Anaconda Co.
773 F.2d 1073 (Tenth Circuit, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
934 F.2d 1452, Counsel Stack Legal Research, https://law.counselstack.com/opinion/woolsey-v-marion-laboratories-inc-ca10-1991.